This bill amends the Federal Food, Drug, and Cosmetic Act to let the Secretary of Health and Human Services order the destruction of any article refused admission into the United States if the Secretary determines it presents a "significant public health concern." It broadens existing language that previously focused on drugs and devices to cover “other article[s]” and creates a new prohibited act making unauthorized movement or introduction (including export) of items ordered destroyed unlawful.
Practically, the bill creates a faster legal path to remove hazardous imports from the supply chain, adds a statutory enforcement hook for misdirecting or exporting those goods, and forces HHS/FDA to revise implementing regulations quickly while remaining consistent with international agreements. That combination reshapes compliance and logistics at ports, for importers, carriers, and warehouses, and raises trade and hazardous-waste disposal questions for operators and regulators.
At a Glance
What It Does
The bill amends 21 U.S.C. §801(a) to allow the Secretary to decide that any refused import presenting a significant public health concern should be destroyed, and it revises statutory language to cover "other articles" beyond drugs and devices. It also adds a new prohibited act to 21 U.S.C. §301 making unauthorized movement or introduction, including export, of articles the Secretary has ordered destroyed unlawful.
Who It Affects
Importers, customs brokers, ocean and air carriers, port and warehouse operators, and foreign exporters of regulated goods face new compliance and loss-risk exposure. It also directs FDA and Customs and Border Protection to coordinate operationally, and pulls in state/local public-health and environmental agencies for disposal and monitoring.
Why It Matters
By converting more refused imports into candidate items for destruction and criminalizing their diversion or export, the bill shortens the pathway for removing hazardous goods from circulation but also shifts disposal costs and legal risks onto supply-chain actors. The requirement that FDA finalize regulatory revisions quickly and honor international agreements adds immediate administrative and trade compliance pressure.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
Under current law, FDA can refuse admission and, in limited circumstances, order destruction of certain drugs or devices described in the statute. This bill expands that authority so the Secretary of Health and Human Services may direct destruction of any article refused admission if the Secretary determines it poses a "significant public health concern." The expansion removes the implicit focus on drugs and devices by inserting "other article," meaning FDA's destruction authority can now apply to a wider range of imported goods that the agency views as hazardous to public health.
The bill also creates a new statutory enforcement tool by adding to the list of prohibited acts an "unauthorized movement, or introduction or delivery for introduction into interstate commerce, including export," of any article the Secretary has ordered destroyed. Treating such conduct as a prohibited act brings the full set of FD&C Act enforcement mechanisms to bear—seizure, injunction, civil penalties, and criminal enforcement where the statute and facts support them—against actors who try to move, sell, or re-export a condemned shipment.To make the authority operational, the bill sets two near-term administrative deadlines.
FDA must finalize necessary regulatory revisions within 90 days of enactment, and the statutory changes become applicable 180 days after enactment. The agency must also ensure regulations align with any binding international agreements.
Operationally, that means ports, carriers, and importers can expect a relatively quick shift in how refused imports are processed: more items could be slated for destruction rather than detention or re-export, and logistics providers will need new procedures for custody, documentation, and lawful disposal.In practice this raises immediate logistical and legal issues that FDA and other agencies will have to address: how "significant public health concern" is defined or operationalized, how owners and consignees are notified and afforded any administrative process before destruction, who pays for safe disposal (especially for hazardous materials), and how destruction orders interact with trade remedies, re-export pathways, and international obligations. The bill directs FDA to take regulatory steps quickly, but it leaves the substantive administrative standards and operational protocols to the agency to develop.
The Five Things You Need to Know
Amends 21 U.S.C. §801(a) so the Secretary may require destruction of any refused import the Secretary determines presents a "significant public health concern.", Edits three sentences in §801(a) to replace the phrase "drug or device" with "drug, device, or other article," widening the statute's scope.
Adds a new prohibited act at 21 U.S.C. §301(jjj) making unauthorized movement, introduction into interstate commerce, or export of items ordered destroyed unlawful.
Requires the Commissioner of Food and Drugs to finalize implementing regulatory revisions within 90 days of enactment and makes the statutory amendments applicable 180 days after enactment.
Directs that FDA’s regulations implementing the changes must be consistent with any applicable international agreements, signaling trade and treaty constraints on how destruction authority is exercised.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Designates the Act as the "Destruction of Hazardous Imports Act." This is purely stylistic but signals congressional intent to focus on imports deemed hazardous to public health.
Amendments to 21 U.S.C. §801(a) — destruction authority
Revises the seventh sentence of §801(a) to add destruction authority whenever the Secretary determines a refused article presents a "significant public health concern." It also broadens three later sentences by inserting "other article" alongside "drug, device," expanding the class of items that can be targeted. Practically, this replaces a narrower destruction pathway focused on specific regulated categories with an open-ended public-health trigger that the Secretary alone will define in practice.
Addition of prohibited act at 21 U.S.C. §301
Adds clause (jjj) to §301 to make unauthorized movement, introduction into interstate commerce, or export of items the Secretary has ordered destroyed a prohibited act. That change creates statutory exposure for anyone who removes, transfers, sells, or attempts to ship condemned goods, enabling FDA enforcement actions under the FD&C Act’s existing remedies.
Applicability timeframe
Sets the effective start for the new authorities at 180 days after enactment. This period gives industry and agencies time to adapt operations but is relatively short for supply-chain actors who may need to change contracts, insurance, and handling procedures.
Regulatory implementation and international consistency
Directs the FDA to finalize necessary regulatory revisions within 90 days and to ensure those rules are consistent with applicable international agreements. The compressed timeline pressures the agency to move quickly, while the international-consistency clause flags potential constraints from trade treaties or sanitary/phytosanitary rules that could limit destructive actions.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Consumers and patients — by creating a faster legal path to remove imports that FDA deems a public-health hazard, the bill reduces the time hazardous goods can reach domestic markets.
- Federal public-health authorities (HHS/FDA) — gains clearer statutory authority and an enforcement hook to prevent diversion or re-export of condemned imports.
- State and local public-health agencies — benefit from reduced risk that hazardous goods will enter local supply chains, easing outbreak response and exposure control.
- Community health settings (clinics, pharmacies) that could otherwise receive tainted imports — fewer opportunities for hazardous products to be redistributed into legitimate medical or consumer channels.
Who Bears the Cost
- Importers and foreign exporters — face increased risk of losing shipments to destruction and bear disposal losses and potentially higher insurance premiums; they must improve screening and documentation to avoid condemnation.
- Carriers, port operators, and bonded warehouses — must build new handling, custody, and disposal procedures, assume short-term storage liabilities, and may face interruption or penalties for noncompliance.
- Customs and Border Protection and FDA operations — will need to coordinate decisions, handle more destruction logistics, and absorb administrative burdens unless appropriations or fee changes offset costs.
- Environmental regulators and waste-management contractors — could see increased volume of hazardous or mixed waste requiring regulated disposal, raising compliance and budget pressures.
Key Issues
The Core Tension
The bill balances two legitimate aims—speeding removal of hazardous imports to protect public health versus protecting property rights, trade commitments, and orderly hazardous-waste management—but it hands broad, discretionary destruction authority to the Secretary without detailed procedural safeguards, creating a trade-off between administrative agility and legal, commercial, and environmental safeguards.
The statute leaves critical definitional and process details to the Secretary, but those details will determine how broad and disruptive the authority becomes. "Significant public health concern" is an imprecise phrase; absent regulatory or guidance language, FDA will have wide discretion to decide which imports qualify. That discretion helps rapid action in emergencies but creates legal and commercial uncertainty for importers and carriers.
The bill's addition of a prohibited act increases enforcement teeth, but it does not prescribe notice, appeal, or administrative-remedy procedures for the owners of condemned goods; the resulting due-process questions are likely to surface in litigation and may constrain aggressive use of the new authority.
Operationally, the bill forces rapid regulatory action (90 days) and puts a 180-day clock on applicability. Those compressed timelines could push FDA and CBP into ad hoc operational rules that later need correction.
The requirement that regulations be "consistent with any applicable international agreements" will complicate matters where destruction could be viewed as a trade barrier or conflict with re-export rights under bilateral treaties—or where consignors request return. Finally, the logistics of safe, legal disposal of hazardous goods (from chemical wastes to contaminated medical devices) will impose real costs and regulatory obligations on ports and waste managers; if not funded or coordinated, that could encourage illicit diversion or improper disposal, undermining the bill's public-health goal.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.